ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.21
0.18%
US Tech 100
20,225.40
0.01%
S&P 500
5,842.91
0.11%
US Dollar vs CAD
1.43568
0.03%
Bitcoin
96,988.80
0.50%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biomea Fusion Inc (BMEA)

  7. Biomea Fusion Inc (BMEA) News

BMEA

Biomea Fusion (BMEA)

Biomea Fusion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BMEA
DateTimeSourceHeadlineSymbolCompany
01/13/20258:00AMGlobeNewswire Inc.Biomea Fusion to Become a Diabetes & Obesity Medicines CompanyNASDAQ:BMEABiomea Fusion Inc
01/07/20258:00AMGlobeNewswire Inc.Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination StudyNASDAQ:BMEABiomea Fusion Inc
01/06/20253:57PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BMEABiomea Fusion Inc
01/06/20256:00AMGlobeNewswire Inc.Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BMEABiomea Fusion Inc
12/20/20242:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMEABiomea Fusion Inc
12/17/20247:10AMGlobeNewswire Inc.Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 DiabetesNASDAQ:BMEABiomea Fusion Inc
12/16/20245:15PMGlobeNewswire Inc.Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)NASDAQ:BMEABiomea Fusion Inc
12/12/20244:02PMGlobeNewswire Inc.Biomea Fusion Announces Oral and Poster Presentations of Icovamenib at the 22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)NASDAQ:BMEABiomea Fusion Inc
12/09/20243:01PMGlobeNewswire Inc.Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute LeukemiaNASDAQ:BMEABiomea Fusion Inc
12/06/20247:00AMGlobeNewswire Inc.Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute LeukemiaNASDAQ:BMEABiomea Fusion Inc
12/02/20243:05PMGlobeNewswire Inc.Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BMEABiomea Fusion Inc
11/18/20247:00AMGlobeNewswire Inc.Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)NASDAQ:BMEABiomea Fusion Inc
11/01/20243:05PMGlobeNewswire Inc.Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BMEABiomea Fusion Inc
10/31/20245:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMEABiomea Fusion Inc
10/30/20243:00PMGlobeNewswire Inc.Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist CandidateNASDAQ:BMEABiomea Fusion Inc
10/29/20244:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMEABiomea Fusion Inc
10/29/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMEABiomea Fusion Inc
10/29/20243:46PMGlobeNewswire Inc.Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BMEABiomea Fusion Inc
10/21/20248:00AMGlobeNewswire Inc.Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219NASDAQ:BMEABiomea Fusion Inc
10/15/20243:05PMGlobeNewswire Inc.Biomea Fusion to Host Conference Call and Webcast on Wednesday, October 30th at 4:30 pm ET to Announce Our Lead Clinical Candidate, BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist and Preclinical Data Combining BMF-219 with a GLP-1 RNASDAQ:BMEABiomea Fusion Inc
10/07/20248:00AMGlobeNewswire Inc.Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)NASDAQ:BMEABiomea Fusion Inc
10/01/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMEABiomea Fusion Inc
10/01/20248:00AMGlobeNewswire Inc.Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes ExpertsNASDAQ:BMEABiomea Fusion Inc
09/27/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMEABiomea Fusion Inc
09/26/20241:00PMGlobeNewswire Inc.FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes TrialsNASDAQ:BMEABiomea Fusion Inc
08/01/20243:05PMGlobeNewswire Inc.Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BMEABiomea Fusion Inc
07/31/20243:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BMEABiomea Fusion Inc
07/31/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BMEABiomea Fusion Inc
07/31/20243:05PMGlobeNewswire Inc.Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BMEABiomea Fusion Inc
06/13/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BMEABiomea Fusion Inc
 Showing the most relevant articles for your search:NASDAQ:BMEA

Your Recent History

USOTC
SGTM
Sustainable Green Team (PK)
NYSE
AMC
AMC Entertainment
USOTC
RDAR
Raadr (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
AZRH
Azure (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
MONI
Moon Equity (PK)
NASDAQ
ENTA
Enanta Pharmaceuticals
NASDAQ
COOP
Mr Cooper
NASDAQ
ILLR
Triller
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
FNMA
Fannie Mae (QB)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
ZHUD
Zhuding (PK)
USOTC
HIRU
Hiru (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads